雖然這篇Finerenone dose鄉民發文沒有被收入到精華區:在Finerenone dose這個話題中,我們另外找到其它相關的精選爆讚文章
[爆卦]Finerenone dose是什麼?優點缺點精華區懶人包
你可能也想看看
搜尋相關網站
-
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#1Kerendia (finerenone) dosing, indications, interactions ...
Medscape - Chronic kidney disease dosing for Kerendia (finerenone), frequency-based adverse effects, comprehensive interactions, contraindications, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#2Finerenone Dosage Guide + Max Dose, Adjustments - Drugs ...
Dose adjustments based on serum potassium levels and daily current dose: Dose:10 mg once daily · Serum Potassium (mEq/L): <=4.8: Increase dose to ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#3Kerendia (Finerenone Tablets): Uses, Dosage, Side ... - RxList
The target daily dose of Kerendia is 20 mg. Measure serum potassium 4 weeks after initiating treatment and adjust dose (see Table 2); if serum ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#4Effect of Finerenone on Chronic Kidney Disease Outcomes in ...
An increase in the dose from 10 to 20 mg once daily was encouraged after 1 month, provided the serum potassium level was 4.8 mmol per liter or ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#5Finerenone Dose-Exposure-Serum Potassium Response ...
由 SC Goulooze 著作 · 被引用 2 次 — Finerenone Dose-Exposure-Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion Criteria.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#6Finerenone Dose–Exposure–Serum Potassium Response ...
Finerenone Dose –Exposure–Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion Criteria.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#7US FDA approves finerenone for the treatment of patients with ...
Finerenone is the first non-steroidal, selective mineralocorticoid receptor (MR) antagonist to demonstrate positive kidney and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#8215341s000lbl.pdf - Accessdata.fda.gov
drug initiation or dosage adjustment of either Kerendia or the moderate ... At a dose 4 times the maximum approved recommended dose, finerenone does not ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#9Finerenone and Cardiovascular Outcomes in Patients With ...
Patients were randomly assigned (1:1) to receive oral finerenone or matching placebo (initial dose of study drug was either 10 or 20 mg OD ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#10Finerenone - an overview | ScienceDirect Topics
Dosing recommendations suggest commencing at a dose of 25 mg daily, increasing to a maximal target dose of 50 mg daily (if tolerated) within 4 weeks. Baseline ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#11Design and Baseline Characteristics of the Finerenone in ...
The starting dose of study drug was selected based on the eGFR measured at the screening visit: patients started on finerenone 10 mg/day or ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#12Efficacy and Safety of Finerenone in Subjects With Type 2 ...
Chronic Kidney Disease, Drug: Finerenone (BAY94-8862) Drug: Placebo, Phase 3 ... Oral tablet; starting dose at 10 mg for subjects with an eGFR between 25 to ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#13Finerenone (Kerendia®) - Straight Healthcare
... spironolactone, any renin inhibitor, or potassium-sparing diuretic was not allowed; Average finerenone dose during the study was 15.1 mg.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#14Effect of Finerenone on Albuminuria in Patients With Diabetic ...
In the Mineralocorticoid Receptor Antagonist Tolerability Study (ARTS), finerenone doses of 2.5 to 10 mg/d reduced albuminuria from baseline ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#15(PDF) Finerenone Dose-Exposure-Response for the Primary ...
Finerenone Dose -Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#16Finerenone - Wikipedia
In the Phase II ARTS-DN study, finerenone dose-dependently reduced urine albumin to creatinine ratio in patients with diabetic kidney disease.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#17Finerenone: Uses, Interactions, Mechanism of Action - DrugBank
It has a moderate duration of action as it is taken once daily, and a wide therapeutic window as patients were given doses from 1.25 mg to 80 mg ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#18Finerenone in Reducing Kidney Failure and Disease ...
The FIDELIO-DKD trial showed that finerenone has salutary effects on CV and ... An increase in the dose from 10 to 20 mg once daily was ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#19Finerenone: MedlinePlus Drug Information
Finerenone : learn about side effects, dosage, special precautions, and more on MedlinePlus.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#20Population Pharmacokinetic and Exposure–Response ...
of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney Disease.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#21Treatment of diabetic kidney disease - UpToDate
If canagliflozin is used, the target dose is 100 mg once daily. ... Finerenone has been studied in patients taking maximally tolerated doses of ACE ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#22finerenone oral: Uses, Side Effects, Interactions ... - WebMD
The dosage is based on your medical condition and response to treatment. Use this medication regularly to get the most benefit from it. To help you remember, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#23Finerenone - Side Effects, Interactions, Uses, Dosage, Warnings
Finerenone is used in adults with chronic kidney disease related to diabetes mellitus type 2, to reduce the risk of:.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#24搜索
Finerenone Dose -Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#25and 20-mg tablets | Safety and dosing - KERENDIA ...
KERENDIA (finerenone) [prescribing information]. Whippany, NJ: Bayer HealthCare Pharmaceuticals, Inc.; July 2021. Return to content; Bakris GL, et al; FIDELIO- ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#26Finerenone | American Journal of Health-System Pharmacy
The recommended starting dosage is 10 mg or 20 mg orally once daily based on estimated glomerular filtration rate (eGFR) and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#27A randomized controlled study of finerenone vs. eplerenone in ...
To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#28Efficacy and safety of finerenone in patients with chronic ...
Keywords: Efficacy; safety; finerenone; chronic kidney disease (CKD); meta- ... the treatment effect of the finerenone dose of 20 mg/d on reducing UACR, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#29Finerenone Datasheet - Selleck Chemicals
In vitro, Finerenone dose-dependently reduces aldosterone-induced smooth muscle cell (SMC) proliferation and prevents aldosteroneinduced endothelial cell ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#30Efficacy and Safety of Finerenone in Chronic Kidney Disease
In recent years, the effectiveness of finerenone for treatment of CKD ... for analysis (finerenone dose ≥10 mg/d), outcomes were pooled.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#31finerenone Uses, Side Effects, Dosage & Interactions
Drug Information on finerenone includes side effects, uses, drug interactions, dosage, drug pictures, overdose symptoms, and what to avoid.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#32Physiologicallyâ•'based pharmacokinetic modeling to predict ...
Finerenone is a nonsteroidal, selective mineralocorticoid receptor ... The pharmacokinetics (PK) of finerenone are dose-linear across the entire range of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#33Finerenone in chronic kidney disease - Nature
Findings from the Finerenone in Reducing Kidney Failure and Disease ... at the maximum dose that did not cause unacceptable adverse events.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#34The use of a novel non-steroidal mineralocorticoid receptor...
Finerenone was equivalent to the existing steroidal mineralocorticoid antagonist (P < .05). However, the efficacy of finerenone appeared to be dose-dependent.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#35Finerenone Improves Cardiovascular, Kidney Outcomes in ...
Cardiovascular (CV) outcomes were improved with finerenone therapy ... The 10 mg dose was given to patients with an estimated glomerular ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#36Finerenone plus SGLT2 inhibition may yield additive CV ...
The nonsteroidal mineralocorticoid receptor antagonist finerenone ... showed equivalence to high-dose finerenone and greater reduction than ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#37A perspective on nonsteroidal mineralocorticoid receptor ...
At comparable natriuretic doses, finerenone provides more potent inhibition of pro-inflammatory and profibrotic genes in the kidney than ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#38Mineralocorticoid Receptor Antagonism in Chronic Kidney ...
Finerenone provoked a dose-dependent reduction in UACR. Drug discontinuation due to hyperkalemia was not observed with placebo and.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#39Kerendia (finerenone) | CenterWatch
Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist. ... The recommended starting dose of Kerendia is based on eGFR.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#40Full article: Differentiation between emerging non-steroidal ...
Finerenone has similar potency to spironolactone, while esaxerenone and KBP-5074 ... In contrast, finerenone lowered blood pressure only at the highest dose ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#41A Randomized Clinical Trial - International Labour Organization
OBJECTIVE: To evaluate the safety and efficacy of different oral doses of the nonsteroidal ... Finerenone demonstrated a dose-dependent reduction in UACR.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#42Biotransformation of Finerenone, a Novel Nonsteroidal ...
The clinical pharmacology of finerenone was initially studied in healthy ... a dose of 10 mg of finerenone (5 ml of 2 mg/ml solution or a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#43What is Finerenone? - GoodRx
Learn about Finerenone (Kerendia), dosing, proper use and what to know before ... an unusual or allergic reaction to finerenone, other medicines, foods, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#44Finerenone vs. Eplerenone: Trial Shows Mixed Results
Dosing of all medications was up-titrated through the study period. The eplerenone group started with a dose of 25 mg every other day, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#45FIDELIO-DKD: Finerenone offers new treatment option for ...
FIDELIO-DKD: The mineralocorticoid receptor antagonist finerenone reduces ... Finerenone was given at a dose of 10 or 20 mg/day according to ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#46Finerenone – Medicines – SPS - Specialist Pharmacy Service
Mineralocorticoid receptor antagonist, blocks the deletorious effects of aldosterone [1]. Dose is 10mg or 20mg, once daily. Epidemiology.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#47Finerenone Tablets (Kerendia) | Relias Media
Withhold the dose if serum potassium is > 5.5 mEq/L. Serum potassium and eGFR should be measured before initiation of treatment and periodically ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#48Finerenone Slows Progression in CKD, Reduces CV Events ...
Finerenone slowed chronic kidney disease (CKD) progression by 18% and ... the screening visit received a starting dose of 10 mg once daily.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#49Finerenone Cuts Kidney, Heart Risks in CKD and T2D
... which time RAS therapy was optimized to a maximally-tolerated labeled dose. 5,734 patients were randomized 1:1 to finerenone or placebo.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#50Finerenone Improves Cardiovascular Outcomes in Patients ...
The phase 3 FIGARO-DKD study evaluating finerenone for the reduction ... or angiotensin receptor blocker therapy at maximum tolerated doses.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#51Mineralocorticoid Receptor Antagonists in Diabetic Kidney ...
They re- ceived different doses of oral finerenone once daily or placebo for 90 days. Finerenone demonstrated a dose-dependent reduction in UACR ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#52Bayer's KERENDIA® (finerenone) Receives US FDA Approval ...
Bayer's KERENDIA® (finerenone) Receives U.S. FDA Approval for ... before initiation of treatment with KERENDIA and dose accordingly.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#53KERENDIA (finerenone) to Treat CKD Associated with Type 2 ...
KERENDIA (finerenone) is a nonsteroidal mineralocorticoid receptor ... The starting dose was determined by screening the estimated ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#54Finerenone Reduces New-Onset Atrial Fibrillation in Patients ...
Patients with CKD and T2D were randomized (1:1) to finerenone or ... with a maximum tolerated dose of either an angiotensin-converting ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#55FDA Approves KERENDIA (Finerenone) to Reduce ... - ASCPT
Dosing of KERENDIA is based on eGFR and serum potassium thresholds. The recommended initial dosage is 10 mg or 20 mg orally once daily, then, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#56Finerenone reduces CKD progression, CV risk - MIMS Malaysia
They were randomized 1:1 to receive finerenone (starting dose 10 mg QD for patients with eGFR 25 to <60 mL/min/1.73 m 2 and 20 mg QD for eGFR ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#57Finerenone Approved as First-in-Class Treatment for Chronic ...
Finerenone, a first-in-class nonsteroidal mineralocorticoid ... Per labeling, finerenone is initiated at a dose of 10 or 20 mg orally once ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#58Finerenone for chronic kidney disease in patients with type 2 ...
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type. 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#59Finerenone (KERENDIA) Approved for Chronic Kidney ...
With approval on July 9, finerenone (Kerendia) becomes the first ... The dosage is then increased after 4 weeks to the target dose of 20 mg ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#60A randomized study of finerenone vs. eplerenone in patients ...
... mineralocorticoid receptor antagonist finerenone in patients with ... of different oral doses of finerenone compared with eplerenone.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#61FDA Approves KERENDIA to Reduce EGFR Decline in Adults ...
The target daily dose of KERENDIA is 20 mg once daily. ... Steady state of finerenone is achieved after 2 days of dosing.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#62Diabetes Distilled: Finerenone significantly reduces renal and ...
FIDELIO-DKD recruited 5734 individuals living with T2D and CKD to receive finerenone or placebo. Finerenone was given at a dose of 10 or 20 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#63finerenone | PeaceHealth
Your doctor may occasionally change your dose. Use the medicine exactly as directed. You may take finerenone with or without food.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#64Bayer Announces KERENDIA® (finerenone) Reduces the ...
FIGARO-DKD: Second Phase III Study for Finerenone to Meet Primary ... therapies and a maximum tolerated labeled dose of ACEis or ARBs. 1 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#65finerenone - North Alabama Urology, PC
Your doctor may occasionally change your dose. Use the medicine exactly as directed. You may take finerenone with or without food.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#66Heart Failure - 第 293 頁 - Google 圖書結果
All investigated doses of finerenone were safe and well tolerated. Finerenone at doses of 2.5–10 mg OD as well as 5 mg BID led to significantly smaller mean ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#67Bayer Expands Finerenone Clinical Development Program ...
The incidence of treatment-emergent adverse events (TEAEs) was similar between eplerenone and all finerenone dose groups.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#68Finerenone in Diabetic Nephropathy - NephJC
finerenone ; fidelio; randomized controlled trial; RCT; NEJM; ... It reduced albuminuria significantly, in a dose-dependent fashion, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#69Finerenone Provides CV, Renal Benefits in Diabetes Across ...
Finerenone reduces the risk for cardiovascular and renal outcomes in ... during treatment with finerenone dose adjustments as needed.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#70Cardiac Events With Type 2 Diabetes, Kidney Disease ...
Finerenone improved cardiovascular outcomes in patients with type 2 ... per minute per 1.73 m 2 received an initial dose of 10 mg once daily, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#71Bayer's finerenone hinders kidney disease, heart disease in ...
Patients received a 10-mg or 20-mg dose of finerenone or placebo on top of the standard of care for CKD. Treatments can include ACE ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#72The novel mineralocorticoid receptor antagonist finerenone ...
In vitro, finerenone dose-dependently reduced aldosterone-induced smooth muscle cell (SMC) proliferation, as quantified by BrdU ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#73finerenone (Kerendia™) - EOCCO.com
Dosage Form. Indication. Quantity Limit finerenone (Kerendia). 10 mg tablets. Adjunct therapy for chronic kidney disease in type 2 diabetes.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#74Finerenone - Glucocorticoid Receptor - TargetMol
Finerenone is a non-steroidal antimineralocorticoid. ... Finerenone. Catalog No. ... You can also refer to dose conversion for different animals.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#75EMEA-001623-PIP01-14-M03 | European Medicines Agency
Active substance. Finerenone ; Therapeutic area. Uro-nephrology ; Decision number. P/0324/2019 ; PIP number. EMEA-001623-PIP01-14-M03 ; Pharmaceutical form(s). Film ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#76BNT162b2 Covid-19 Vaccine over 6 Months of Follow-up
Finerenone in Kidney Disease and Type 2 Diabetes ... or more days after the second vaccine dose was evaluated in participants 12 or older.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#77Finerenone | CAS#:1050477-31-0 | Chemsrc
Articles of Finerenone are included as well. ... Animal Model: Twelve-week-old MWF rat[1] Dosage: 10 mg/kg Administration: P.o.; ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#78Hypertension: New Frontiers: A Textbook of Cardiology
Finerenone showed a dose-dependent reduction in albuminuria, with 1.8% of patients developing hyperkalemia with treatment discontinuation (7.5–20 mg doses).
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#79Renin-Angiotensin System: Past, Present and Future
Finerenone dose -dependently reduced albuminuria up to 33 and 38% in the 15 and 20 mg groups with only small increases in serum potassium (+0.17± 0.46 and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#80Chronic Kidney Disease, Dialysis, and Transplantation ...
Finerenone produced a dose-dependent reduction in albuminuria when added to a RAS blocker. After 90 days of treatment, finerenone decreased UACR in a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#81Advances & Innovations in Heart Failure (AIHF): A Textbook ...
Collagen metabolism in than in each of the finerenone dose groups. These results cultured adult rat cardiac fibroblasts: response to angiotensin show a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#82Hypertension: A Companion to Braunwald's Heart Disease E-Book
... the nonsteroidal mineralocorticoid receptor antagonist finerenone for its ... plus finerenone (dose 1.25 to 20 mg/d) or placebo over a 3-month period.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#83CKD and Diabetes- By Saro Arakelians, PharmD- Episode #193
AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features. © 2022 Google LLC.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#84Finerenone | New Drug Approvals
Posts about Finerenone written by DR ANTHONY MELVIN CRASTO Ph.D. ... The temperature should rise to a maximum of 10 ° C (slow dosage).
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#85ACC 2022 Late Breaking Cardiology Study Results | DAIC
... Parallel Group, Dose-finding Phase 2 Study Comparing the Safety of ... Fidelity Analyses: Finerenone and Cardiorenal Outcomes by History ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#86Finerenone|1050477-31-0 - MOLNOVA
Finerenone (BAY 94-8862) is a potent, selective, orally available mineralocorticoid ... elicits a significant and dose-dependent increase in the urinary ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#87Late-breaking clinical trials announced for ACC.22
... A Placebo-controlled Double-blind Dose-ranging Trial. ... Fidelity Analyses: Finerenone and Cardiorenal Outcomes by History of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#88Stage 2 Kidney Disease: Symptoms, Treatment, Coping, and ...
Kerendia (finerenone) is a prescription medicine that can reduce the risk of ... Taking doses that are too high, even of common drugs like aspirin, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#89용도, 복용량, 부작용, 상호 작용, 경고 - 케렌디아
Kerendia (Finerenone Tablet)는 부작용, 복용량, 약물 상호 작용, 경고, ... The dose of Kerendia could be titrated during the study, with a target dose of 20 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#90Critical Care Nephrology E-Book - 第 372 頁 - Google 圖書結果
Dosing recommendations suggest commencing at a dose of 25 mg daily, increasing to ... Finerenone demonstrated a dose-dependent reduction in urine albumin to ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#91Offer your patients dosing that is one capsule, twice daily 1
Advise the patient to not make up for a missed dose. Do not exceed the recommended maximum daily dosage of 300 mg. 1. The dosage of OFEV can be reduced, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#92[護理新知] JAMA:Finerenone可有效緩解糖尿病腎病變 ...
Finerenone 是一種新型非類固醇礦物性皮質激素受體拮抗劑(mineralocorticoid receptor antagonist, MRA),體外試驗顯示,Finerenone比spironolactone ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#93Drug Study Offers New Hope to Patients with Both Chronic ...
"We now have evidence that doctors can safely slow diabetic kidney disease progression and reduce cardiovascular event rates using finerenone, a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#94SGLT2 inhibitors: updated advice on the risk of diabetic ...
... low food intake, weight loss, infection, surgery, vomiting, a decrease in insulin dose, or poor control of diabetes.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?>
finerenone 在 コバにゃんチャンネル Youtube 的最讚貼文
finerenone 在 大象中醫 Youtube 的精選貼文
finerenone 在 大象中醫 Youtube 的精選貼文